injection of 50% glucose (Sigma-Aldrich) solution at a dose of 2 g/kg body weight was administered to mice
However, research is also needed on the efficacy and cost-effectiveness of different strategies to facilitate long-term WL maintenance for example the use of lower medication doses or the less frequent dosing of obesity pharmacotherapy for WL maintenance
Fat loss Studies suggest that most weight lost with retatrutide comes from body fat rather than lean tissue, although preserving muscle mass still depends on: consuming adequate protein undertaking resistance exercise maintaining regular physical activity These remain important parts of any medically supervised weight management programme
Moreover, compared with other GLP-1 RAs, subcutaneous semaglutide (1 mg) and oral semaglutide (14 mg) administration yielded an improved reduction in body weight (WMD: 3.72 kg, 95% CI: 4.16 to 3.28, and WMD: 2.03 kg, 95% CI: 2.91 to 1.15, respectively)
Learn which option offers the best results and how they work in your weight loss journey